Plain-English translation of NCT07419932 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Thyroid Cancer research guide →This trial is testing whether giving patients multikinase inhibitors, receptor inhibitors (like RET inhibitors or BRAF/MEK inhibitors), or combinations with PD-1 inhibitors before surgery can help shrink advanced thyroid cancers and make them easier to remove. Researchers will compare patients who receive this medication before surgery to those who go straight to surgery, and track how well each group does.
Advanced thyroid cancer that has grown into nearby tissues is very serious and hard to treat. Doctors hope that giving this medication before surgery will shrink the tumor, make it safer to remove completely, and help patients live longer and healthier lives.
You likely qualify if…
You likely don't qualify if…
If you join, you'll either receive targeted medications for at least two treatment cycles before having surgery to remove your thyroid, or you'll go straight to surgery based on what you and your doctors decide is best. Throughout the study, doctors will monitor how your cancer responds using imaging tests, blood work, and tissue samples, and they'll track your health and outcomes over time.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China